1,814
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

A rare case of IgE kappa monoclonal gammopathy of undetermined significance identified in a Swedish female

, &
Pages 385-388 | Received 09 Feb 2021, Accepted 08 May 2021, Published online: 07 Jun 2021

References

  • Kyle RA, Rajkumar SV. Epidemiology of the plasma-cell disorders. Best Pract Res Clin Haematol. 2007;20:637–664.
  • Hejl C, Mestiri R, Carmoi T, et al. IgE monoclonal gammopathy: a case report and literature review. Clin Biochem. 2018;51:103–109.
  • Johansson SG, Bennich H. Immunological studies of an atypical (myeloma) immunoglobulin. Immunology. 1967;13:381–394.
  • Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020;95:548–567.
  • Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003;78:21–33.
  • Morris C, Drake M, Apperley J, et al. Efficacy and outcome of autologous transplantation in rare myelomas. Haematologica. 2010;95:2126–2133.
  • Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538–e548.
  • Landgren O, Graubard BI, Kumar S, et al. Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey. Blood Cancer J. 2017;7:e618.
  • Kyle RA, Therneau TM, Rajkumar SV, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;354(13):1362–1369.
  • Malling HJ, Djurup R, Stahl Skov P, et al. Clinical and immunological aspects of a case of monoclonal hyper-IgE. Isolation of IgE-protein, estimation of basophil cell bound IgE and histamine release. Allergy. 1985;40:250–256.
  • Brivio R, Cappellani A, Carpenedo M, et al. IgE monoclonal gammopathy: the clinical relevance to perform the immunofixation using IgE antisera. Int J Lab Hematol. 2020;42:e237–e239.
  • Gamundi Grimalt E, Morandeira Rego F, Clapes Puig V, et al. IgE multiple myeloma: a new case report. Clin Chem Lab Med. 2017;55:e37–e40.
  • Caldini A, Balboni F, Parronchi P, et al. A rare condition: IgE type monoclonal gammopathy of undetermined significance. Clin Chem Lab Med. 2014;52:e183–e185.
  • Ludwig H, Vormittag W. Benign" monoclonal IgE gammopathy. Br Med J. 1980;281:539–540.
  • Schieferdecker A, Horber S, Ums M, et al. Comparison of three different serum-free light-chain assays-implications on diagnostic and therapeutic monitoring of multiple myeloma. Blood Cancer J. 2020;10(2):2.
  • Rawstron AC, Orfao A, Beksac M, et al. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica. 2008;93:431–438.
  • Avet-Loiseau H, Garand R, Lode L, et al. Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants. Blood. 2003;101:1570–1571.
  • Lakshman A, Alhaj Moustafa M, Rajkumar SV, et al. Natural history of t(11;14) multiple myeloma. Leukemia. 2018;32(1):131–138.
  • Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346:564–569.
  • Macro M, Andre I, Comby E, et al. IgE multiple myeloma. Leuk Lymphoma. 1999;32:597–603.
  • Rajkumar SV, Kumar S. Multiple myeloma current treatment algorithms. Blood Cancer J. 2020;10:94.